medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2006, Number 2

<< Back Next >>

Rev Inst Nal Enf Resp Mex 2006; 19 (2)

Surgical approaches to lung cancer. Facts and some reflections

Ibarra-Pérez C

Language: Spanish
References: 41
Page: 143-147
PDF size: 119.11 Kb.


ABSTRACT

Stage I and II non-small cell lung cancer (NSCLC) should be resected, but there is mounting evidence for the use of preoperative induction and postoperative adjuvant therapy in stages IB and II, as being able to prolong life. Some patients in stage IIIA should undergo induction therapy, and then have re-staging of the mediastinum by CT/PET or redo mediastinoscopy before considering resection. Stages IIIB and IV are non-surgical, except very selected cases. Reflections are made regarding the control of cigarette smoking, the difficult access of patients from developing countries to the recent costly medical, pharmacological and technical advances; reflections are also made related to some ethical issues regarding medical and surgical treatment of NSCLC.


REFERENCES

  1. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer. a review of the current evidence. Chest 2003;123(1 Suppl):137-146.

  2. Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest 2003;123(1 Suppl):147-156.

  3. Gamez C, Rosell R, Fernandez A, et al. PET/CT fusion scan in lung cancer: current recommendations and innovations. J Thorac Oncol 2006;1:74-77.

  4. Toloza EM, Harpole L, Detterbeck F, McCrory DC. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123(1 Suppl): 157-166.

  5. Detterbeck FC, DeCamp MM Jr, Kohman LJ, Silvestri GA. Invasive staging: the guidelines. Chest 2003;123(1 Suppl):167-175.

  6. Murthy SC, Rice TW. Thoracic incisions. In: Pearson FG, Cooper JD, Deslauriers J, et al, editors. Thoracic surgery. 2ª ed. New York: Churchill Livingstone; 2002.p.120-138.

  7. Fry WA. Thoracic incisions. In: Shields TW, LoCicero J, Ponn RB, Rusch VW, editors. General thoracic surgery. 6ª ed. Philadelphia: Lippincott Williams & Wilkins;2005.p.411-419.

  8. Ponn RB, LoCicero III J, Daly BDT. Surgical treatment of non-small cell lung cancer. In: Shields TW, LoCicero III J, Ponn RB, Rusch VW, editors. General thoracic surgery. 6a ed. Philadelphia: Lippincott Williams & Wilkins; 2005.p.1548-1587.

  9. Jett JR, Scott WJ, Rivera MP, Sause WT. Guidelines on treatment of stage IIIB non-small cell lung cancer. Chest 2003;123(1 Suppl):221-225.

  10. Detterbeck FC, Jones DR, Kernstine KH, Naunheim KS. Special treatment issues. Chest 2003;123(1 Suppl): 244-258.

  11. Ibarra-Pérez C, Kelly-García J, Fernández-Corzo MA. Tratamiento del cáncer broncogénico de células no pequeñas localmente avanzado, etapa IIIB, con énfasis en la cirugía. Rev Inst Nal Enf Resp Mex 2000;13:222-226.

  12. Downey RJ. Non-small cell lung cancer with a solitary hematogenous metastasis. Thorac Surg Clin 2004;14: 265-269.

  13. Pisters KMW. Multimodality management of early-stage lung cancer. In: Franco KL, Putnam JB, editors. Advanced therapy in thoracic surgery . 2a ed. Hamilton:BC Decker;2005.p.61-67.

  14. Berghmans T, Paesmans M, Meert AP, et al. Survival improvement in resectable non-small cell lung cancer with (neo) adjuvant chemotherapy: results of a meta-analysis of the literature. Lung Cancer 2005;49:13-23.

  15. Booth CM, Shepherd FA. Adjuvant chemotherapy for resected non-small cell lung cancer . J Thorac Oncol 2006;1:180-187.

  16. Diagnosis and management of lung cancer: ACCP evidence-based guidelines. Chest 2003;123(1 Suppl).

  17. Robinson LA, Wagner H Jr, Ruckdeschel JC. Treatment of stage IIIA non-small cell lung cancer. Chest 2003;123(1 Suppl):202-220.

  18. Roth JA, Atkinson EN, Fossella F, et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-smallcell lung cancer. Lung Cancer 1998;21:1-6.

  19. Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 1999;26:7-14.

  20. De Waele M, Hendriks J, Lauwers P, et al. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy. Eur J Cardiothorac Surg 2006;29:240-243.

  21. 21.Feins RH. Clinical trials in lung cancer: truth, justice, and the American way. Ann Thorac Surg 2000;70: 1139-1141.

  22. Ginsberg RJ. Non-small cell lung cancer. Surgical management. In: Pearson FG, Coper JD, Deslauriers J, et al, editors. Thoracic surgery. 2a ed. New York: Churchill-Livingstone;2002.p.837-859.

  23. Little AG, Rusch VW, Bonner JA, et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg 2005;80:2051-2056.

  24. Kuzdzal J, Zielinski M, Papla B, et al. Transcervical extended mediastinal lymphadenectomy-the new operative technique and early results in lung cancer staging. Eur J Cardiothorac Surg 2005;27:384-390.

  25. Smulders SA, Smeenk FW, Janssen-Heijnen ML, Wielders PL, de Munck DR, Postmus PE. Surgical mediastinal staging in daily practice. Lung Cancer 2005;47:243-251.

  26. Goodney PP, Lucas FL, Stukel TA, Birkmeyer JD. Surgeon specialty and operative mortality with lung resection. Ann Surg 2005; 241:179-184.

  27. Martin-Ucar AE, Waller DA, Atkins JL, Swinson D, O’Byrne KJ, Peake MD. The beneficial effects of specialist thoracic surgery on the resection rate of non-smallcell lung cancer. Lung Cancer 2004;46:227-232.

  28. Wright G. Letter to the Editor. Lung Cancer 2005; 47:425-426.

  29. Allen MS, Darling GE, Pechet TT et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006;81:1013-1019.

  30. Rami-Porta R, Wittekind C, Goldstraw P, et al. Complete resection in lung cancer surgery: proposed definition. Lung Cancer 2005; 49:25-33.

  31. Kuzdzal J, Zielinski M. Letter to the Editor. Lung Cancer 2005; 51:131-132.

  32. Rami-Porta, Wittekind C, Goldstraw P. Reply to letter to the Editor. Lung Cancer 2005;51:133-134.

  33. Keller SM, Adak S, Wagner H, Johnson DH. Mediastinal lymph node dissection improves survival in patients with stages II and IIIA non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg 2000; 70:358-365.

  34. Wu Y, Huang ZF, Wang SY, Yang XN, Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002;36:1-6.

  35. Passlick B, Kubuschock B, Sienel W, Thetter O, Pantel K, Izbicki JR. Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases —results of a preliminary study—. Eur J Cardiothorac Surg 2002; 21:520-526.

  36. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 2003; 21:1029-1034.

  37. Lardinois D, Suter H, Hakki H, Rousson V, Betticher D, Ris HB. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 2005; 80:268-274.

  38. Ludwig MS, Goodman M, Miller DL, Johnstone PA. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest 2005;128:1545-1550.

  39. Allen MS. Mediastinal lymph node dissection for nonsmall cell lung cancer. J Thorac Cardiovasc Surg 2005;130:241-242.

  40. Scagliotti GV, Novello S. Current development of adjuvant treatment of non-small cell lung cancer. Clin Lung Cancer 2004; 6(Suppl 2):63-70.

  41. 41.Ito M, Minamiya Y, Kawai H, et al. Intraoperative detection of lymph node micrometastasis with flow cytometry in non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;130:753-758.




2020     |     www.medigraphic.com